Archive for February, 2008

The Misuse of Fentanyl is Deadly

Friday, February 29th, 2008

Fentanyl is a medication that is prescribed to those with intense pain due to chronic or fatal illnesses. The composition of Fentanyl is similar to morphine and heroin, as it contains a synthetic opiate.

An overdose of Fentanyl will cause symptoms of respiratory depression and eventually respiratory arrest.

In February, the U.S. Food and Drug Association (FDA) issued it’s second warning regarding the misuse of Fentanyl since 2005.

Both patient and doctor error have lead to numerous fatalities through the misuse of Fentanyl. The FDA has only approved the use of Fentanyl for those with chronic pain, who are already accustomed to the use of opioids.

In order for the patient to be accustomed to an opioid, they must have consistently used the medication 24-hours a day for a week or more.

The FDA has been alerted to physicians prescribing Fentanyl to patients with non-chronic pain. Doctors have prescribed Fentanyl to patients suffering from post-surgery pain, migraine headaches and those that have never taken an opioid medication.

Accidental overdoses of Fentanyl have also been linked to frequent application of the pain patches. Another common misuse is from allowing the Fentanyl pain patch to become hot, which increases the delivery of Fentanyl through the skin.

If you or a loved one has suffered serious or fatal illness from misuse of Duragesic or Fentanyl pain patches, you may be entitled to compensation. Contact a Duragesic attorney at Cappolino Dodd Krebs LLP at 1-800-460-0606. An experienced Fentanyl attorney will be able to evaluate if you are eligible to seek compensation.

Trasylol Recall – Recall by Bayer Could Have Saved Thousands of Lives

Thursday, February 28th, 2008

          Medical researcher Dr. Dennis Mangano concluded in a recent report that the delayed recall of the Bayer drug Trasylol caused the death of approximately 22,000 people. Trasylol is a drug that is used during open-heart surgery to stem bleeding and as many as one third of all heart bypass patients in the United States were given Trasylol during the peak of its use by doctors.
          Dr. Mangano’s study (published in January of 2006) showed that the medicine can cause kidney failure and increased death in its patients. The Food and Drug Administration advisory panel discussed the study and its findings at their September 2006 meeting but declined to recall Trasylol. Dr. Mangano alleges that this is at least in part because Bayer did not tell the FDA the serious side effects of Trasylol had also been found in Germany.
          Trasylol was finally recalled last November, and for many the delay was a death sentence. If the FDA had voted to recall Bayer’s Trasylol at that meeting in 2006, or if Bayer had issued a voluntary recall in light of the negative findings, more than 20,000 lives could have been saved. Bayer is currently facing product-liability lawsuits from victims and families of victims of Trasylol. If you or someone you love has been exposed to Trasylol, contact the lawyers at the law firm of Cappolino Dodd  Krebs LLP at 1-800-460-0606 for legal counsel as soon as possible.

Fentanyl Pain Patch Recalled a Second Time

Tuesday, February 26th, 2008

A second voluntary recall has been issued for Fentanyl pain relief patches. 14 lots of Actavis generic Fentanyl CII were recalled because of a fold-over defect that could possibly expose patients and caregivers to Fentanyl gel.

Exposure to Fentanyl gel may result in serious or fatal adverse effects, such as respiratory depression and overdose.

The Actavis recall follows the recall of all 25 microgram/hour PriCara and Sandoz Fentanyl patches. The PriCara and Sandoz Fentanyl patches were recalled because of a cut along the side of the Fentanyl gel reservoir, possibly causing exposure to the Fentanyl gel.

The lots affected by the recall include 25-, 50-, 75-, and 100-microgram/hour strengths. The lot numbers are:

  • 27261 (expiration date 5/09)
  • 27317 (expiration date 5/09)
  • 27318 (expiration date 6/09)
  • 27319 (expiration date 6/09)
  • 27391 (expiration date 6/09)
  • 27409 (expiration date 6/09)
  • 27475 (expiration date 7/09)
  • 27476 (expiration date 6/09)
  • 27488 (expiration date 6/09)
  • 27514 (expiration date 7/09)
  • 27536 (expiration date 7/09)
  • 27537 (expiration date 8/09)
  • 27538 (expiration date 8/09)
  • 27545 (expiration date 7/09)

Damaged patches should not be used under any circumstances. Damaged or cut fentanyl patches should be stored in a safe, tightly-sealed container, out of reach of children. To avoid exposure to the fentanyl gel, do not handle the patch directly. Do not re-use a container in which you stored damaged or cut fentanyl patches.

If you or a loved one has suffered serious illness or death due to exposure to Fentanyl, contact a Fentanyl pain patch attorney at Cappolino Dodd Krebs LLP at 1-800-460-0606. An experienced Fentanyl pain patch lawyer will be able to evaluate if you are eligible to seek compensation.

Duragesic/Fentanyl Pain Patch Safety

Friday, February 22nd, 2008

The recent recall of Duragesic and other Fentanyl pain patches have brought to light safety concerns regarding the highly potent drug.

The U.S. Food and Drug Association is investigating the reported deaths of patients using Duragesic and Fentanyl patches. A precautionary recall has been issued for all 25 microgram/hour Duragesic and Fentanyl patches with expiration dates on or before December 2009.

For all patients that are not affected by the recall and choose to continue using Duragesic or Fentanyl patches, consider the following safety information:

  • Prescriptions for Fentanyl should always be the lowest dose needed
  • Duragesic or Fentanyl patches should only be used by those suffering from chronic pain and who are not currently taking other narcotic painkillers
  • Follow the directions of doctors and pharmacists exactly
  • Store in a safe place away from children

Duragesic and Fentanyl patches are a very strong prescription narcotic. Serious side effects, such as respiratory depression and death by overdose are possible if not administered properly or damaged patches are used.

Watch for the following signs of an overdose:

  • Shallow and/or troubled breathing
  • Extreme tiredness, sleepiness or sedation
  • Inability to talk, walk or think normally
  • Feeling confused
  • Feeling faint or dizzy

If any of these symptoms occur, seek medical attention immediately.

If you or a loved one has suffered serious or fatal illness from damaged Duragesic or Fentanyl pain patches, you may be entitled to compensation. Contact a Duragesic attorney at Cappolino Dodd Krebs LLP at 1-800-460-0606. An experienced Fentanyl attorney will be able to evaluate if you are eligible to seek compensation.

Recall of Duragesic/Fentanyl Pain Relief Patches

Tuesday, February 19th, 2008

Certain fentanyl patches are being voluntarily recalled after reports were made of deaths related to the use of the medication for pain management.

In the United States, all 25 microgram/hour Duragesic CII skin patches, which are sold by PriCara, and all patches sold by Sandoz Inc. are being recalled in cooperation with the U.S. Food and Drug Administration. The Duragesic and Fentanyl recall applies to Canada as well.

Check expiration dates on all Duragesic or Sandoz fentanyl patches. The fentanyl recall products that are affected have expiration dates on or before December 2009.

The recalled fentanyl patches may have a cut along the side of the drug reservoir within the patch. This could result in the release of fentanyl gel from the reservoir, possibly exposing patients and caregivers to the gel.

Fentanyl is a powerful opioid medication used for pain management. Exposure to the fentanyl gel may lead to serious and possibly fatal effects, such as respiratory depression and overdose.

Damage to the patch can be seen upon opening the sealed foil pouch that contains the patch.

Fentanyl patches that are cut or damaged should not be used. If contact with fentanyl gel is made, rinse the affected area with water. Do not use soap.

Damaged or cut fentanyl patches should be stored in a safe, tightly-sealed container, out of reach of children. To avoid exposure to the fentanyl gel, do not handle the patch directly. Do not re-use a container in which you stored damaged or cut fentanyl patches.

If you or a loved one has suffered illness or death as a result of exposure to fentanyl gel, you may be entitled to compensation. Please contact a Duragesic lawyer at Cappolino Dodd Krebs LLP at 1-800-460-0606. An experienced Fentanyl attorney will be able to evaluate if you are eligible to seek compensation.